Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Plum Alley Investments Funds Cordex Systems: Detecting Heart Disease Early
  • USA - English


News provided by

Plum Alley

Mar 30, 2017, 08:00 ET

Share this article

Share toX

Share this article

Share toX


New York, NY (PRWEB) March 30, 2017 -- “It is both humbling and tragic that in the time it takes me to compose this note of gratitude, at least twenty women will die of cardiovascular disease in the US – a disease that is 80-90% preventable. It is this singular fact that drives us at Cordex to create technology to address the health needs of women and men with a device to detect the earliest signs of heart disease.” Dr. Kathy Magliato, Founder, CEO and Chief Medical Officer, Cordex Systems

The women and men of Plum Alley Investments elected to invest in both this visionary founder and innovative new technology that has the potential to save millions of lives.

Post this

Plum Alley Investments, a company that forms syndicates of its members to invest in innovative private companies with women entrepreneurs and gender-diverse teams, announced the closing of a $1.19 million investment in Cordex Systems as part of the company’s Series A capital raise.

Cordex Systems is an early stage company that has created a proprietary, innovative and patented SmartCuff TM that is designed to detect the early presence of cardiovascular disease. The technology, which is non-invasive, non-imaging and non-operator dependent, is a point-of-care test that takes less than 10 minutes to perform. The Founder and CEO, Dr. Kathy Magliato MD, MBA, FACS is a nationally recognized expert in heart disease and one of the few women cardiothoracic surgeons in the country, a field in which women represent only 3% of the total surgeons. Having performed surgery and interventions in top medical facilities including Cedars-Sinai in LA, Dr. Magliato saw firsthand that most cardiac interventions are invasive and come at the extreme end-stage of heart disease when transplants are often needed for survival. Cordex Systems' patented SmartCuffTM aims to detect the earliest signs of heart disease with the hopes of preventing further cardiovascular deterioration and improving the quality of life.

Cardiovascular disease is the No. 1 cause of death in the world, accounting for more than 17.3 million deaths per year, a number that is expected to grow to more than 23.6 million by 2030. Over 85 million Americans are living with heart disease and 2,200 Americans die every day – that’s one death every 40 seconds. 90% of cardiovascular diseases can be prevented, if diagnosed early, by addressing behavioral risk factors such as tobacco use, unhealthy diet, obesity, physical inactivity and controlling blood pressure and diabetes. However, with the currently available diagnostic approaches, cardiovascular disease is very hard to diagnose at this critical early, treatable stage.

“When you look at the numbers, it is truly shocking that heart disease continues to be so widespread.” Dr. Magliato has the real life and death experience with her cardiac patients and has been a spokesperson for the American Heart Association. “It takes a person with true commitment and a broad base of business and medical skills to bring forward a solution. The women and men of Plum Alley Investments elected to invest in both this visionary founder and innovative new technology that has the potential to save millions of lives,” said Deborah Jackson, CEO of Plum Alley.

This Company’s $5 million+ Series A round was funded by a broad base of professional and strategic investors, family offices and C-suite former and current executives from major fortune 500 companies including Pfizer, PwC, Morgan Stanley, Schwab and NBC Universal along with the Plum Alley syndicate. Other investors include Venetto Ltd., following the initial funding from National Institutes of Health, Maryland Technology Development Company (TEDCO), and Maryland Industrial Partnerships (MIPs).

Linnea Roberts, a member of Plum Alley and investor in the syndicate had this to say: “I invest in the most promising companies with gender diverse founding teams because these teams will make the highest returns. Cordex Systems is a company we need in the world and Dr. Kathy Magliato epitomizes a talented physician and business woman with impressive results to date. She will get the job done.”

Plum Alley Investments http://www.plumalley.co is a modern investing platform where women and men engage in a new way around investing in purposeful and innovative private companies. Cordex Systems is the 5th syndicate investment in a private company in the last 14 months with their syndicates aggregating nearly $3 million. The other Plum Alley syndicate investments have been in companies with innovations in early childhood education, SAAS innovative hiring and unconscious bias technology, stem cell creation of bone, and a digital market for private investigators. Plum Alley has over 200 members and invests across sectors but has a screen for women entrepreneurs in the founding team and companies with potential for strong financial and personal returns.

For Immediate Release

For additional information on Cordex Systems or Plum Alley, please contact Dara(at)plumalley(dot)co

Dara Kagan, Plum Alley, http://plumalley.co, +1 914-424-4581, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.